Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2022-08-11 00:00:00 ET · period of report 2022-08-09 · accession 0001883850-22-000056 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-08-11 | 2022-08-09 | REGN | POON CHRISTINE A | Dir | S - Sale+OE | $620.91 | -15.0K | 1,872 | -89% | -$9.31M |
| D | 2022-08-11 | 2022-08-09 | REGN | POON CHRISTINE A | Dir | M - OptEx | $177.82 | +15.0K | 16.9K | +801% | +$2.67M |
| D | 2022-08-11 | 2022-08-09 | REGN | POON CHRISTINE A | Dir | M - OptEx | $0.00 | -15.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-09 | S | D | 6,814 | $620.47 | 10,058 | D | — | — | (F1) Represents volume-weighted average price of sales of 6,814 shares of Company stock on August 9, 2022 at prices ranging from $620.20 to $620.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 9, 2022 at each separate price. |
| 2 | Common | Common Stock | 2022-08-09 | M | A | 15,000 | $177.82 | 16,872 | D | — | — | |
| 3 | Common | Common Stock | 2022-08-09 | S | D | 8,186 | $621.27 | 1,872 | D | — | — | (F2) Represents volume-weighted average price of sales of 8,186 shares of Company stock on August 9, 2022 at prices ranging from $621.01 to $621.33. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 9, 2022 at each separate price. |
| 4 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-08-09 | M | D | 15,000 | $0.00 | 0 | D | $177.82 · — to 2023-01-02 | 15,000 Common Stock | (F3) The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. |